Demitrios Dedousis, MD

American Board of Internal Medicine:
Internal Medicine, 2022
Medical Oncology, 2024
Hematology, 2025

American Board of Medical Genetics and Genomics:
Clinical Genetics and Genomics, 2025

Fellowship in the ACMG Summer Genetics Scholars Program
Saint Peter’s University Hospital, 05/2015

State University of New York Downstate College of Medicine:
Medical Education Pathway, 05/2018

Fox Chase Cancer Center
Hearst Foundation Clinical Cancer Genetics Fellowship, 06/2025

City of Hope
Intensive Course in Genomic Cancer Risk Assessment, 03/2025

Cornell University
Magna Cum Laude, 05/2014
Distinction in Research, 05/2014

State University of New York Downstate College of Medicine
Distinction in Research, 05/2018
Global Health Elective Travel Award, St. John’s Medical College in Bangalore, India, 5/2018

Lewis Katz School of Medicine at Temple University
Sol Sherry Award for Excellence in Research, 06/2024

American Society of Clinical Oncology
Conquer Cancer Merit Award, 06/2025

American College of Medical Genetics
Member, 2016 – Present

American Medical Association
Member, 2016–Present

American Society of Clinical Oncology
Member, 2019–Present

American Society of Hematology
Member, 2019–Present

Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
Member, 2024–Present

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-31, Dr. Dedousis has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.